C&B Minicast

When Gambling Goes Mobile: A Public Health Concern

Send us Fan Mail [https://www.buzzsprout.com/2451115/fan_mail/new] In this episode of C&B Minicast, we explore the rapid rise of mobile gambling — now a $100+ billion industry that lives right in the palm of your hand. From betting during dinner to scrolling in class, access has never been easier… or more constant. We break down the science behind gambling behavior, why men make up nearly 70% of users, and how increased accessibility is driving higher participation — and risk. Most importantly, we discuss the public health implications, including the 2–5% of users who develop problematic behaviors and the growing vulnerability among younger populations. — #CBHealthCharleston #MentalHealthAwareness #GamblingAddiction #BehavioralHealth #DigitalWellness #PublicHealth #AddictionAwareness #CharlestonMentalHealth

Childhood Trauma in South Carolina with Dr. Rochelle Hanson

Send us Fan Mail [https://www.buzzsprout.com/2451115/fan_mail/new] In this important minicast, we’re joined by Rochelle Hanson, Ph.D. to discuss the realities and long-term impact of childhood trauma and why early support and awareness matter. Together, we describe how adverse experiences can shape emotional development, relationships, and mental health across the lifespan—and how communities, caregivers, and professionals can play a role in creating safer, more supportive environments for children. This conversation highlights the importance of recognizing trauma, reducing stigma, and expanding access to compassionate, evidence-based, trauma-informed care across South Carolina. A meaningful listen for parents, educators, caregivers, and anyone passionate about supporting healthier futures for the next generation. 🎧 Listen to the latest minicast — link in bio. - #CBHealthCharleston #MentalHealthAwareness #ChildhoodTrauma #TraumaInformedCare #SouthCarolina #CharlestonMentalHealth #CommunityCare #SupportOurKids #MentalHealthMatters

AI and the Future of Mental Health Care

Send us Fan Mail [https://www.buzzsprout.com/2451115/fan_mail/new] In this timely episode, we’re joined by Elliott Friedman, a healthcare IT expert with over 20 years of experience and a cautious early adopter of AI. Together, we unpack the growing role of artificial intelligence in therapy and clinical settings—and the critical questions every provider should be asking. From AI’s authoritative tone to the very real risk of hallucinated information, we explore:  • What happens when AI becomes your note-taker?  • Where does sensitive data actually go?  • How do we safeguard against errors disguised as “facts”?  • And how can clinicians use AI responsibly without compromising care? This is a must-listen for anyone curious about the intersection of technology, ethics, and mental health.  Tune in to Season 2, Episode 12 - #CBHealthCharleston #MentalHealthAwareness #AIEthics #DigitalHealth #HealthcareIT #AIMentalHealth #TherapyInnovation #CharlestonMentalHealth #ResponsibleAI

Psychedelic-Assisted Therapy with Dr. Jennifer Jones

Send us Fan Mail [https://www.buzzsprout.com/2451115/fan_mail/new] Can psychedelic-assisted therapy transform the treatment of depression, PTSD, and anxiety? In this special in-depth episode, Dr. Jennifer Jones joins us to explore the science, promise, and ethical considerations of psychedelic-assisted therapy. From psilocybin to MDMA and ketamine, we discuss how these treatments may reshape the future of mental health care. Tune in to the full interview. — #CBHealthCharleston #MentalHealthAwareness #PsychedelicTherapy #KetamineTreatment #MDMAWellness #PsilocybinResearch #ClinicalTrials #CharlestonMentalHealth #TherapyThatHeals

Can Psychedelics Change the Future of Mental Health Treatment?

Send us Fan Mail [https://www.buzzsprout.com/2451115/fan_mail/new] Can psychedelics change the future of mental health treatment? In this episode, we provide an overview of psychedelic research over the past five years.  Studies on psilocybin, MDMA, ketamine and esketamine are discussed.   Curious about participating in a trial? Visit ClinicalTrials.gov. #CBHealthCharleston #MentalHealthAwareness #PsychedelicResearch #KetamineTherapy #PsilocybinHealing #MDMAWellness #ClinicalTrials American  Psychiatric Association. (2022). Position  statement on the use of psychedelic and empathogenic agents for mental health conditions. American Psychiatric Association. https://www.psychiatry.org/ [https://www.psychiatry.org/] Bogenschutz, M. P., Ross, S., Bhatt, S., Baron, T., Forcehimes, A. A., Laska, E., ... & Khalsa, S. S. (2022). Percentage of heavy drinking days following psilocybin-assisted treatment for alcohol use disorder: A randomized clinical trial. JAMA  Psychiatry, 79(10), 953–962. https://doi.org/10.1001/jamapsychiatry.2022.2096 [https://doi.org/10.1001/jamapsychiatry.2022.2096] Carhart-Harris, R. L., Giribaldi, B., Watts, R., Baker-Jones, M., Murphy-Beiner, A., Murphy, R., ... & Nutt, D. J. (2021). Trial of psilocybin versus escitalopram for depression. New  England Journal of Medicine, 384(15), 1402–1411. https://doi.org/10.1056/NEJMoa2032994 [https://doi.org/10.1056/NEJMoa2032994] Daly, E. J., Trivedi, M. H., Janik, A., Li, H., Zhang, Y., Li, X., ... & Drevets, W. C. (2019). Efficacy of esketamine nasal spray plus oral antidepressant vs antidepressant plus placebo for relapse prevention in treatment-resistant depression: A randomized clinical trial. JAMA  Psychiatry, 76(9), 893–903. https://doi.org/10.1001/jamapsychiatry.2019.1189 [https://doi.org/10.1001/jamapsychiatry.2019.1189] Goodwin, G. M., Aaronson, S. T., Alvarez, O., Arden, P. C., Baker, A., Bennett, J. C., ... & Wiegand, F. (2022). Single-dose psilocybin for a treatment-resistant episode of major depression. New  England Journal of Medicine, 387(18), 1637–1648. https://doi.org/10.1056/NEJMoa2206443 [https://doi.org/10.1056/NEJMoa2206443]